XTL Biopharmaceuticals Ltd. (XTLB) NASDAQ
2.29
-0.11(-4.58%)
Currency In USD
- General
- Statistics
- Historical Data
- Profile
- Financials
2.29
-0.11(-4.58%)
Currency In USD
| Market Cap | 853,923.56 |
| Enterprise Value | 620,923 |
| P/E Ratio | -4.13 |
| PEG Ratio | 0.05 |
| Price/Sales Ratio | 13.23 |
| Price/Book Ratio | 0.78 |
| Enterprise/Revenue | 12.72 |
| Enterprise/EBITDA | -6.17 |
| Fiscal Year | December 31, 2024 |
| Most Recent Quarter | December 31, 2024 |
| Profit Margin | -2.28 |
| Operating Margin | -4.82 |
| Return On Assets | -0.12 |
| Return On Equity | -0.27 |
| Revenue | 451,000 |
| Revenue/Share | 0 |
| Gross Profit | 3,000 |
| EBITDA | -930,000 |
| Net Income | -1.03M |
| Diluted EPS | -9.6 |
| Total Cash | 1.14M |
| Total Cash/Share | 0 |
| Total Debt | 138,000 |
| Total Debt/Equity | 0.03 |
| Current Ratio | 0.61 |
| Book Value Per Share | 0.01 |
| 52-Week Change | -52.29 |
| 52-Week High | 10.28 |
| 52-Week Low | 2.12 |
| Moving Average 50 Days | 2.63 |
| Moving Average 200 Days | 3.65 |
| Average Volume | 1.89M |
| Shares Outstanding | 2.37M |
| % Held by Institutions | 69.13 |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | 1:4 |
| Last Split Date | March 25, 2026 |